As part of its long-standing commitment to promoting the medical and scientific debate in Italy on the latest diagnostic and therapeutic developments in the thromboembolic and hemorrhagic diseases field, Kedrion participated as a platinum sponsor in the XXVII National Congress of the Italian Society for Haemostasis and Thrombosis (SISET), which was held from November 3 to 5 in Perugia with the title of “Hemostasis and Thrombosis: the Present and the Future.”
In addition to participating with a booth, the company supported the “Women and Congenital Hemorrhagic Diseases: Management of Hemorrhagic Risk and Anemia” lunch session held on November 4. The meeting was moderated by Prof. Paolo Gresele – President of SISET – and the speakers were Prof. Mariasanta Napolitano (Palermo), who addressed the topic of von Willebrand disease and hemophilia in women, and Prof. Elvira Grandone (Foggia), who discussed the treatment of anemia in heavy menstrual bleeding and postpartum.
“The lunch session on ‘Women and Congenital Hemorrhagic Diseases’ focused on a topic of great relevance, considering that gynecological hemorrhages are not only widespread and still largely neglected, but are also characterized by a number of unique features that need to be highlighted and discussed,” said SISET President, Paolo Gresele. “This is why it’s so important today to draw the attention of the entire medical and scientific community – including hemostasis and thrombosis experts, who are often called upon to globally manage women’s health issues, including hemorrhagic issues – to the consequences of excessive bleeding, including sideropenic anemia.”
On the closing day of the event, Saturday, November 5, Kedrion also supported a coffee session, which was moderated by Prof. Raimondo De Cristofaro (Rome), which hosted the speech by Prof. Antonia Follenzi (Novara), focused on the results of the research she is conducting on endothelial cells, highlighting specific biological and molecular processes.